Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 28

Results For "RIL"

1250 News Found

FUJIFILM launches advanced therapeutic endoscopy system in India
News | April 22, 2025

FUJIFILM launches advanced therapeutic endoscopy system in India

The system is powered by advanced imaging innovations such as Amber-red Color Imaging, Triple Noise Reduction, and Extended Dynamic Range Image Processing


MoS Health Jadhav inaugurates FSSAI’s stakeholder consultation on sustainable packaging
News | April 21, 2025

MoS Health Jadhav inaugurates FSSAI’s stakeholder consultation on sustainable packaging

Over 1500 stakeholders representing food businesses, packaging industries, recycling associations, regulatory bodies, environmental organizations, consumer groups, farmer groups, government departments participated in the consultation


Rockwell Automation empowers NKP Pharma achieve regulatory compliance
Digitisation | April 17, 2025

Rockwell Automation empowers NKP Pharma achieve regulatory compliance

By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11


Ami Organics to change name as Acutaas Chemicals
News | April 16, 2025

Ami Organics to change name as Acutaas Chemicals

This change is subject to the approval of the shareholders of the company, the Ministry of Corporate Affairs and other statutory and regulatory authorities,


Dabur appoints Sriram Padmanabhan as Head of Health Care Business
People | April 14, 2025

Dabur appoints Sriram Padmanabhan as Head of Health Care Business

Padmanabhan brings over two decades of extensive experience in FMCG sector


Aurobindo receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
Drug Approval | April 14, 2025

Aurobindo receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg

The product will be launched in Q1FY26


Aurolife Pharma gets 11 observations from USFDA for Raleigh plant
Drug Approval | April 14, 2025

Aurolife Pharma gets 11 observations from USFDA for Raleigh plant

The company does not expect this development to have any material impact on the current business operations


Fredun secures tender from TNMSC for supply of generic pharma products
News | April 14, 2025

Fredun secures tender from TNMSC for supply of generic pharma products

The supply of these goods is set to commence within the first quarter of FY26


Cipla receives USFDA approval for Protein-bound Paclitaxel for Injectable Suspension
Drug Approval | April 12, 2025

Cipla receives USFDA approval for Protein-bound Paclitaxel for Injectable Suspension

Protein-bound Paclitaxel is indicated for the treatment of metastatic breast cancer, locally advanced or metastatic non-small cell lung cancer and metastatic adenocarcinoma of the pancreas